Ann: Letter to Shareholders, page-103

  1. 543 Posts.
    lightbulb Created with Sketch. 62
    I have re-watched the zoom meeting recording again, and I have decided to be with Imugene till its' success by 5 years. 5 years is ok for me. Importantly, Imugene will be successful with Azer-cell first, then CF33 and OnCARlytics. they are treating cancer not common disease. it's really tough time during the processing but it will be great success once achieved. They are struggling with money which is true but the all clinic trials still on track.

    5 YEARS OK FOR ME.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.002(13.6%)
Mkt cap ! $89.60M
Open High Low Value Volume
1.2¢ 1.4¢ 1.1¢ $536.2K 43.66M

Buyers (Bids)

No. Vol. Price($)
28 7796352 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 5433998 28
View Market Depth
Last trade - 14.42pm 27/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.